“By combining its weight-loss drug tirzepatide with eloralintide, a new drug that mimics a hormone involved in signaling fullness, Eli Lilly helped people with type 2 diabetes lose an average of 23.3 percent of their body weight over 48 weeks on the highest dose, compared with 14.8 percent for patients taking tirzepatide alone,” reports The Doomslayer.
The Wall Street Journal explains:
Read Full Article: https://libertyunyielding.com/2026/10/09/weight-loss-drugs-grow-even-more-effective/
